Market Cap 2.15B
Revenue (ttm) 235.13M
Net Income (ttm) 5.75M
EPS (ttm) N/A
PE Ratio 25.33
Forward PE 20.92
Profit Margin 2.45%
Debt to Equity Ratio 0.00
Volume 489,000
Avg Vol 1,626,064
Day's Range N/A - N/A
Shares Out 131.84M
Stochastic %K 70%
Beta 1.42
Analysts Sell
Price Target $16.71

Company Profile

Aurinia Pharmaceuticals Inc. is a biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs. It offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. The company also develops AUR200, a dual inhibitor of B cell activating factor and a proliferation inducing ligand for the potential treatment of autoimmune diseases. It has a collaboration and license agreement wit...

Industry: Biotechnology
Sector: Healthcare
Phone: 250 744 2487
Fax: 250 708 4345
Address:
#140, 14315 – 118 Avenue, Edmonton, Canada
Martinsucks
Martinsucks Dec. 27 at 5:27 PM
$AUPH can someone explain this patent news in layman's terms. Are we expecting a p.r that extends patent to 2042? These lawyers and there nonsense terms.
1 · Reply
US_Bull
US_Bull Dec. 27 at 2:53 PM
$AUPH No incorrect as the COM US Patent No. 7,332, 472 is a continuation of the parent 10,274,255 with a non-provisional filing date of 10/17/2002. Add 20 years to this gives you October 17, 2022 original expiration and then we got the max 5 year Patent Term Adjustment in light of FDA review which bumps it up to October 17, 2027. So no Aurinia got the max patent term adjustment in light of Hatch Waxman Act. This is it you can't get more extension than 5 years from original expiration.
1 · Reply
OutputOmen
OutputOmen Dec. 27 at 12:39 PM
$AUPH Investors are weighing durability against tactical noise; pipeline visibility needs clearer corroboration — measurable traction would outweigh rhetoric. Durability will separate winners from speculation.
1 · Reply
Heldnova
Heldnova Dec. 27 at 9:47 AM
$AUPH Since the original patent expired October 17, 2022 doesn't the 5 year extension only give us an additional 2 years?
1 · Reply
Solomonwisdom7
Solomonwisdom7 Dec. 27 at 3:50 AM
$AUPH Thanks for sharing that fact!
0 · Reply
SmartOptionsAlert
SmartOptionsAlert Dec. 27 at 3:08 AM
🔎 $AUPH Options Scan Update (21:08 CT) No standout unusual options activity right now. Bias: Neutral • Waiting for stronger flow https://smartoptions.ai
0 · Reply
twakey
twakey Dec. 27 at 12:45 AM
$AUPH Are you Still holding?
1 · Reply
Work2Live
Work2Live Dec. 26 at 11:19 PM
$AUPH This was posted a few minutes ago on Reddit… squeeezzee!!!
2 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 26 at 10:21 PM
Enter: $AUPH Calls Strike Price: $17 Expiry Date: JAN 16 2026 Buy in Price: $0.35 - $0.37 Sell Price: $0.58 Profit : +65% (Turn every $1 into $1.65) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
jdoldnumber7
jdoldnumber7 Dec. 26 at 9:59 PM
$AUPH We have closed up 18 out of past 22 weeks. Not many stocks can claim that....
0 · Reply
Latest News on AUPH
Wall Street Breakfast Podcast: FDA Executive Controversy

Nov 3, 2025, 7:31 AM EST - 7 weeks ago

Wall Street Breakfast Podcast: FDA Executive Controversy


Aurinia Responds to Now Retracted LinkedIn Post

Sep 29, 2025, 8:27 PM EDT - 3 months ago

Aurinia Responds to Now Retracted LinkedIn Post


Aurinia Pharmaceuticals: Shareholder Pressure And Sales Growth

Apr 26, 2025, 10:54 AM EDT - 8 months ago

Aurinia Pharmaceuticals: Shareholder Pressure And Sales Growth


Aurinia Pharmaceuticals: There's Still Time For Sales Growth

Feb 21, 2025, 4:09 PM EST - 11 months ago

Aurinia Pharmaceuticals: There's Still Time For Sales Growth


3 Biotech Stocks With Notable Insider Buying

Jan 22, 2025, 12:29 PM EST - 1 year ago

3 Biotech Stocks With Notable Insider Buying

AZN COGT JAZZ ONC XBI ZYME


3 Small Biotech Stocks With The 'Big Mo' Right Now

Sep 19, 2024, 12:54 PM EDT - 1 year ago

3 Small Biotech Stocks With The 'Big Mo' Right Now

CORT VRDN


Aurinia Pharmaceuticals: This Recovery Can Continue

Sep 18, 2024, 4:41 AM EDT - 1 year ago

Aurinia Pharmaceuticals: This Recovery Can Continue


Aurinia Announces Board Restructuring

Sep 12, 2024, 4:05 PM EDT - 1 year ago

Aurinia Announces Board Restructuring


Martinsucks
Martinsucks Dec. 27 at 5:27 PM
$AUPH can someone explain this patent news in layman's terms. Are we expecting a p.r that extends patent to 2042? These lawyers and there nonsense terms.
1 · Reply
US_Bull
US_Bull Dec. 27 at 2:53 PM
$AUPH No incorrect as the COM US Patent No. 7,332, 472 is a continuation of the parent 10,274,255 with a non-provisional filing date of 10/17/2002. Add 20 years to this gives you October 17, 2022 original expiration and then we got the max 5 year Patent Term Adjustment in light of FDA review which bumps it up to October 17, 2027. So no Aurinia got the max patent term adjustment in light of Hatch Waxman Act. This is it you can't get more extension than 5 years from original expiration.
1 · Reply
OutputOmen
OutputOmen Dec. 27 at 12:39 PM
$AUPH Investors are weighing durability against tactical noise; pipeline visibility needs clearer corroboration — measurable traction would outweigh rhetoric. Durability will separate winners from speculation.
1 · Reply
Heldnova
Heldnova Dec. 27 at 9:47 AM
$AUPH Since the original patent expired October 17, 2022 doesn't the 5 year extension only give us an additional 2 years?
1 · Reply
Solomonwisdom7
Solomonwisdom7 Dec. 27 at 3:50 AM
$AUPH Thanks for sharing that fact!
0 · Reply
SmartOptionsAlert
SmartOptionsAlert Dec. 27 at 3:08 AM
🔎 $AUPH Options Scan Update (21:08 CT) No standout unusual options activity right now. Bias: Neutral • Waiting for stronger flow https://smartoptions.ai
0 · Reply
twakey
twakey Dec. 27 at 12:45 AM
$AUPH Are you Still holding?
1 · Reply
Work2Live
Work2Live Dec. 26 at 11:19 PM
$AUPH This was posted a few minutes ago on Reddit… squeeezzee!!!
2 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 26 at 10:21 PM
Enter: $AUPH Calls Strike Price: $17 Expiry Date: JAN 16 2026 Buy in Price: $0.35 - $0.37 Sell Price: $0.58 Profit : +65% (Turn every $1 into $1.65) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
jdoldnumber7
jdoldnumber7 Dec. 26 at 9:59 PM
$AUPH We have closed up 18 out of past 22 weeks. Not many stocks can claim that....
0 · Reply
Yarrow
Yarrow Dec. 26 at 9:51 PM
$AUPH Why no bump for 5 yr patent extension. Isn't that worth billions? delayed reaction?
1 · Reply
Toni19
Toni19 Dec. 26 at 9:39 PM
$AUPH Interesting research and observation!🤷‍♂️ Thank you to @BABYHAIR
0 · Reply
Auphiliate
Auphiliate Dec. 26 at 9:28 PM
$AUPH Good news! Thanks @US_Bull ! 👏
1 · Reply
Martinsucks
Martinsucks Dec. 26 at 9:01 PM
$AUPH c'mon Peter. Buyout Monday, 33.50. want to buy more Srpt and capr with the winnings. Get it done!
1 · Reply
Handbiker
Handbiker Dec. 26 at 8:59 PM
$AUPH fingers crossed for a PR on Monday or Tuesday about targeted conditions for AUR200 🤞 Hoping they also do a sneak preview of potential 2025 earnings like they did 3 years ago or so
0 · Reply
Solomonwisdom7
Solomonwisdom7 Dec. 26 at 8:58 PM
$AUPH That makes a statement. The Tutes aren’t buying for the dividend (there isn’t one). lol They are long but I believe they are expecting a big gain soon!
1 · Reply
Cfl41m
Cfl41m Dec. 26 at 8:19 PM
0 · Reply
Dameistro
Dameistro Dec. 26 at 8:11 PM
$AUPH can't wait to see qrt4
0 · Reply
jdoldnumber7
jdoldnumber7 Dec. 26 at 7:34 PM
$AUPH C'mon Sugarbritches, I want another green week! Stars are aligning!
0 · Reply
Dameistro
Dameistro Dec. 26 at 7:32 PM
$AUPH Definitely keeping a lid on it this time! Been auphly quiet lately...
0 · Reply
Solomonwisdom7
Solomonwisdom7 Dec. 26 at 6:32 PM
$AUPH I hope you’re correct but what information leads you to believe AUPH is in talks for a BO?
1 · Reply
US_Bull
US_Bull Dec. 26 at 5:46 PM
$AUPH Final 5 year extension came in I guess that is how much it means to the mgmnt that they were not even bothered to PR it as per usual.
5 · Reply